Skip to Main Content

Paper Details

Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study.
Mol Cancer Ther
10
2020
200445019, CPI211, G-protein-coupled receptor, T399A, TBXA2R, TBXA2R single-nucleotide polymorphism, TPr, Thromboxane, Thromboxane Receptor, VE-cadherin, cancer, chronic venous hypertension, mice, mouse, patients, primary tumors, rs200445019, thromboxane A2-prostanoid, thromboxane A2-prostanoid receptor, tumor, tumor cell, tumor cells, vascular endothelial cells
Author NameAffiliation
Heidi E HammVanderbilt University Medical Center
Robert R LavieriVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Meghan Morrison JolyVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Jill M PulleyVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
  • 1 - 4

Datasets

Release 1.2